Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-04-10

FDA Approved: LAMOTRIGINE KIT — Supplemental Application (OWP Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Lamotrigine Kit, a generic lamotrigine product by OWP Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine Kit (Lamotrigine)

Snippet

SUPPL AP for LAMOTRIGINE KIT (LAMOTRIGINE)